Zobrazeno 1 - 10
of 68
pro vyhledávání: '"A. Jaén Morago"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sánchez-Muñoz, Alfonso, Plata-Fernández, Yessica Maria, Fernández, Margarita, Jaén-Morago, Ana, Fernández-Navarro, Monica, de la Torre-Cabrera, Capilla, Ramirez-Tortosa, Cesar, Lomas-Garrido, Maria, Llácer, Casilda, Navarro-Perez, Victor, Alba-Conejo, Emilio, Sánchez-Rovira, Pedro
Publikováno v:
In Clinical Breast Cancer April 2013 13(2):146-152
Autor:
Luis Manso Sánchez, Maria Lomas Garrido, Ana Jaén Morago, Paula Espinosa Olarte, Cristina Pernaut Sánchez, Pedro Sánchez Rovira
Publikováno v:
Future oncology (London, England). 14(7s)
Although advancing age can greatly increase the complexities of treating metastatic breast cancer, chronological age alone is insufficient to determine the type or intensity of treatment. Older patients require an individualized approach that takes i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75b3863a19f8df97a3d54e7cd57ea9c0
https://pubmed.ncbi.nlm.nih.gov/29611758
https://pubmed.ncbi.nlm.nih.gov/29611758
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
E. Martínez Ortega, J. Pérez Del Palacio, G. Pérez Chica, M. Ruiz Sanjuan, A.L. Ortega Granados, M.Á. Moreno Jiménez, C. Díaz Navarro, C. De La Torre Cabrera, R. Dueñas García, F.J. García Verdejo, P. Sanchez Rovira, N. Luque Caro, F. Vicente Pérez, N. Cárdenas Quesada, M. Fernández Navarro, B. Márquez Lobo, A. Jaén Morago
Publikováno v:
Journal of Thoracic Oncology. 12:S2009-S2010
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6beb9f1b15d646b3edb053f2764a155c
https://doi.org/10.1016/j.jtho.2017.09.954
https://doi.org/10.1016/j.jtho.2017.09.954
Autor:
Alfonso Sánchez-Muñoz, Pedro Sánchez-Rovira, J. Martínez, A. Jaén-Morago, C. Ramírez Tortosa, C. de la Torre-Cabrera, I. Chacon, Nuria Ribelles, Ana Maria García-Tapiador, Mónica Fernández-Navarro, E. Martínez-Ortega, R. Dueñas-García, Eva Carrasco, María Dolores Martín-Salvago, A. I. Rueda, Basilio Dueñas, Ana Laura Ortega-Granados
Publikováno v:
American Journal of Clinical Oncology. 33:432-437
Purpose: To evaluate the pathologic complete response (pCR) rate of a combination of epirubicin (E) and cyclophosphamide (C) followed by paclitaxel (P) and gemcitabine (G) (+ trastuzumab[T]) in Her2+ patients) in a sequential and dose-dense schedule
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db8f0f4b77319af51b78f382dc20fd48
https://doi.org/10.1097/coc.0b013e3181b4eff9
https://doi.org/10.1097/coc.0b013e3181b4eff9
Autor:
Alfonso Sánchez-Muñoz, Mónica Fernández-Navarro, R. Dueñas-García, Francisco de Asís Ruiz Morales, Ana Maria García-Tapiador, María Dolores Martín-Salvago, Pedro Sánchez-Rovira, Capilla de la Torre-Cabrera, A. Jaén-Morago, Ana Laura Ortega-Granados, Basilio Dueñas, E. Martínez-Ortega, César Ramírez-Torosa, Ana Isabel Rueda
Publikováno v:
Clinical and Translational Oncology. 10:646-653
To study the role of breast cancer molecular subtypes according to hormone receptors and HER2 status as a predictive factor for pathological complete response (pCR) to neoadjuvant chemotherapy.Eligible patients received one of the two chemotherapy sc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f93487dbfdc3137c62627c91aed63d4e
https://doi.org/10.1007/s12094-008-0265-y
https://doi.org/10.1007/s12094-008-0265-y
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Reinald Pamplona Gras, Caridad Díaz Navarro, Francisco José García Verdejo, V Rivas, JA Olid, Maria Lomas Garrido, Olga Genilloud, Ricardo Collado Martín, Pedro Sánchez Rovira, José Pérez del Palacio, Ana Laura Ortega Granados, Mónica Fernández Navarro, Francisca Vicente Pérez, Ana Jaén Morago, Mariona Jové Font, David Fernández Garay, Capilla de la Torre Cabrera, Natalia Luque Caro, Cesar Ramirez Tortosa, María Ruiz Sanjuan
Publikováno v:
Journal of Clinical Oncology. 35:e23053-e23053
e23053 Background: Breast cancer (BC) is most common cancer in women and development of new technologies for understanding molecular changes involved in BC progression is essential. Metabolic changes precede phenotypic changes, due to cellular regula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2282e08f5cf4e2a38c82b30bdb865dd
https://doi.org/10.1200/jco.2017.35.15_suppl.e23053
https://doi.org/10.1200/jco.2017.35.15_suppl.e23053
Autor:
Victor Navarro Pérez, Natalia Luque Caro, David Fernández Garay, María Ruiz Sanjuan, Miguel Angel Moreno Jimenez, Pedro López Leiva, Ana Laura Ortega Granados, Capilla de la Torre Cabrera, Maria Carmen Álamo de la Gala, Rosario Dueñas García, Esther Martínez Ortega, Francisco José García Verdejo, Yessica Plata Fernández, Juan Francisco Marín Pozo, Nuria Cárdenas Quesada, Rosa Millán García, Mónica Fernández Navarro, Ana Jaén Morago, Maria Lomas Garrido, Pedro Sánchez Rovira
Publikováno v:
Journal of Clinical Oncology. 35:e20515-e20515
e20515 Background: It is known that outcome of patients included in clinical trials have a better outcome than patients treated with standard therapy. This is a retrospective case-control study of outcome of patients with stage III and IV non-small c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bcd7587aeac157279242a7c8cce955f
https://doi.org/10.1200/jco.2017.35.15_suppl.e20515
https://doi.org/10.1200/jco.2017.35.15_suppl.e20515